UK backs push to take pan-coronavirus vaccine toward the clinic
UK government provides £1.9 million ($2.5 million) to move pan-coronavirus synthetic DNA vaccine toward human testing.
Archives for August 27, 2020
Bavarian Nordic warns COVID-19 may delay plans for RSV vaccine
Bavarian Nordic weighs options for RSV vaccine amid concerns COVID-19 response will drive down prevalence of pathogen.
SubjectWell eyes diversity in COVID-19 vaccine trials
The clinical trials marketplace company reportedly is connecting sites with 10,000 patients a month, with 40% of them from non-white groups.
Trade group accuses FDA of rendering COVID-19 plasma units unusable
FDA faces criticism over labeling that has allegedly made “hundreds, if not thousands, of in-date, ready to transfuse” COVID-19 plasma units unusable.